🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsOral GLP-1 AgonistsCost projections for oral non-peptide GLP-1 agonists — anyone have experience? Page 5

Cost projections for oral non-peptide GLP-1 agonists — anyone have experience?

Dr.CardioMD Tue, Feb 24, 2026 at 10:03 AM 23 replies 1,028 viewsPage 5 of 5
pam_stl
Member
267
1,123
Oct 2024
St. Louis, MO
Mar 10, 2026 at 1:32 PM#21

Following on from LibrarianMeg — and this may be the naive question:

What did you change at the same time, and can you separate the two now?

45 20Dr.ObesityMed, HealthEcon_DC, PedsEndoPhilly and 42 others
Reply Quote Save Share Report
lori_vegas
Member
378
1,678
Aug 2024
Las Vegas, NV
Mar 15, 2026 at 2:10 AM#22
bri_stats said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

I read this differently from bri_stats, on substance rather than tone. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

Last edited: Mar 15, 2026 at 4:10 AM
44 19bbq_ray_KC, oliver_london, tane_welly and 41 others
Reply Quote Save Share Report
KristenIndy
Member
623
2,678
May 2024
Indianapolis, IN
Mar 19, 2026 at 2:51 PM#23
bri_stats said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Agreed on the substance. I would put less weight on the timescale, because two months of anything is not enough to distinguish a trend from a wobble.

43 18Dr.GutHealth, amsterdam_pete, LondonLisa and 40 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
newstart_MO
New Member
12
45
Feb 2026
Springfield, MO
Mar 24, 2026 at 3:34 AM#24
bri_stats said:
The distinction that resolves most of these threads is between what is true on average and what is true for one person.

Genuinely useful, thank you. I had the facts and not the framework.

42 17TrialNerd_Beth, HPLC_Greg, LibrarianMeg and 39 others
Reply Quote Save Share Report
CarlaRPh_TPA
Senior Member
1,890
8,234
Jan 2024
Tampa, FL
Mar 28, 2026 at 4:20 PM#25

Adding the clinical framing, because it changes how the question reads. The version of this that has an answer is narrower than the version being asked. Narrow it and it becomes tractable; leave it broad and the thread will produce nine confident and incompatible replies.

Last edited: Mar 28, 2026 at 8:20 PM
41 16emily_PDX, Dr.SleepRoch, laura_annarbor and 38 others
Reply Quote Save Share Report
1345

Similar Threads

Orforglipron Phase 3 ATTAIN-1 topline — oral non-peptide GLP-116 replies
Oral semaglutide 50mg (Rybelsus HD) — OASIS program results12 replies
Danuglipron BID dosing — Pfizer oral GLP-1 update7 replies
Oral vs injectable GLP-1: bioavailability and efficacy comparison5 replies
Orforglipron food interaction profile — no fasting requirement15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register